Surveillance and Treatment Protocols to Detect and Treat Hepatitis B Virus Reactivation in Hepatitis B Surface Antigen–Negative/Antibody to Hepatitis B Core Antigen–Positive Patients Receiving Chemotherapy for Onco-Hematologic Malignancies
- 10 March 2011
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (8), e210
- https://doi.org/10.1200/jco.2010.33.6016
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination ChemotherapyJournal of Clinical Oncology, 2010
- Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without RituximabJournal of Clinical Oncology, 2009
- Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphomaBritish Journal of Haematology, 2008
- Definition of hepatitis B infection for the best practice in chronic disease and in immunosuppressed patientsJournal of Hepatology, 2008
- Prophylaxis and treatment of hepatitis B in immunocompromised patientsDigestive and Liver Disease, 2007